Re:OpenAI to Become For-Profit Company
by throwup238 on Friday September 27, 2024 @01:40AM
(#41666620)
> Maybe at this scale.
I don't think it's unprecedented, even at this scale.
Novo Nordisk, the pharmaceutical company behind Semaglutide (aka Ozempic) with a market cap >$600 bilion, was founded by the Novo Nordisk Foundation before going public. The latter now has an endowment of over $150 billion and owns a significant fraction of the public company.
I don't think it's unprecedented, even at this scale.
Novo Nordisk, the pharmaceutical company behind Semaglutide (aka Ozempic) with a market cap >$600 bilion, was founded by the Novo Nordisk Foundation before going public. The latter now has an endowment of over $150 billion and owns a significant fraction of the public company.